(주)지앤지셀

{
  "address": "경상북도 의성군",
  "ceo_name": "이상수",
  "certificate": [
    {
      "cert_number": "20180114064",
      "changes": "",
      "disclosure_date": "2018-12-12",
      "first_cert_date": "2018-12-12",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-12-12 ~ 2020-12-11"
    },
    {
      "cert_number": "20200116087",
      "changes": "",
      "disclosure_date": "2020-12-14",
      "first_cert_date": "2018-12-12",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-12-12 ~ 2022-12-11"
    },
    {
      "cert_number": "20221102010035",
      "changes": "",
      "disclosure_date": "2022-11-02",
      "first_cert_date": "2018-12-12",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2022-12-12 ~ 2025-12-11"
    },
    {
      "cert_number": "20251112010005",
      "changes": "",
      "disclosure_date": "2025-11-12",
      "first_cert_date": "2018-12-12",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2025-12-12 ~ 2028-12-11"
    }
  ],
  "company_name": "(주)지앤지셀",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 1075000000,
      "cost_of_sales": 0,
      "current_assets": 541580000,
      "current_liabilities": 1599601000,
      "gross_profit": 10000000,
      "net_income": 629783000,
      "net_income_bs": 629783000,
      "non_current_assets": 1492444000,
      "non_current_liabilities": 13124000,
      "non_operating_expenses": 63843000,
      "non_operating_income": 1010671000,
      "operating_profit": -317045000,
      "revenue": 10000000,
      "sga_expenses": 327045000,
      "total_assets": 2034024000,
      "total_equity": 421299000,
      "total_liabilities": 1612725000
    },
    "2023": {
      "capital_stock": 1091650000,
      "cost_of_sales": 77053000,
      "current_assets": 798636000,
      "current_liabilities": 1655702000,
      "gross_profit": 164157000,
      "net_income": -248398000,
      "net_income_bs": -248398000,
      "non_current_assets": 1557773000,
      "non_current_liabilities": 29772000,
      "non_operating_expenses": 72249000,
      "non_operating_income": 580000,
      "operating_profit": -176729000,
      "revenue": 241210000,
      "sga_expenses": 340886000,
      "total_assets": 2356409000,
      "total_equity": 670935000,
      "total_liabilities": 1685474000
    },
    "2024": {
      "capital_stock": 1101650000,
      "cost_of_sales": 74300000,
      "current_assets": 1205849000,
      "current_liabilities": 1602593000,
      "gross_profit": 148936000,
      "net_income": -220619000,
      "net_income_bs": -220619000,
      "non_current_assets": 1847967000,
      "non_current_liabilities": 701766000,
      "non_operating_expenses": 95474000,
      "non_operating_income": 1205000,
      "operating_profit": -126350000,
      "revenue": 223236000,
      "sga_expenses": 275286000,
      "total_assets": 3053816000,
      "total_equity": 749457000,
      "total_liabilities": 2304359000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2022-09-08"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2022-09-08"
    },
    {
      "amount": "200,000,000",
      "changes": "200,000,000",
      "date": "2022-06-17"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2020-12-29"
    }
  ],
  "main_products": "의약품, 화장품 연구 및 개발업, 동물의약품 연구 및 개발업",
  "phone": "031-703-****",
  "years": [
    2024,
    2023,
    2022
  ]
}